CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases-Reference-Cited by-同舟云学术

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases

Published:2017-07-13 Issue:11 Volume:66 Page:1449-1461
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Paulsen Erna-Elise^ORCID,Kilvaer Thomas K.,Rakaee Mehrdad,Richardsen Elin,Hald Sigurd M.,Andersen Sigve,Busund Lill-Tove,Bremnes Roy M.,Donnem Tom

Funder

Helse Nord RHF

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/article/10.1007/s00262-017-2039-2/fulltext.html

Reference49 articles.

1. Brambilla E, Travis WD (2014) Lung cancer. In: Stewart BW, Wild CP (eds) World cancer report 2014. International Agency for Research on Cancer, Lyon, pp 350–361

2. Kerr KM, Bubendorf L, Edelman MJ et al (2014) Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer. Ann Oncol 25:1681–1690. doi: 10.1093/annonc/mdu145

3. Lovitch SB, Rodig SJ (2016) The role of surgical pathology in guiding cancer immunotherapy. Annu Rev Pathol 11:313–341. doi: 10.1146/annurev-pathol-012615-044125

4. Yuan J, Hegde PS, Clynes R et al (2016) Novel technologies and emerging biomarkers for personalized cancer immunotherapy. J Immunother Cancer 4:3. doi: 10.1186/s40425-016-0107-3

5. Fridman WH, Pagès F, Sautès-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12:298–306. doi: 10.1038/nrc3245

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An extensive immunohistochemical analysis of 290 ovarian adult granulosa cell tumors with 29 markers;Virchows Archiv;2024-06-21

2. Identification of Two Distinct Immune Subtypes in Hepatitis B Virus (HBV)-Associated Hepatocellular Carcinoma (HCC);Cancers;2024-03-30

3. Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-02-28

4. NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy;Frontiers in Immunology;2024-02-07

5. The Tumor Microenvironment Affects Circulating Tumor Cells Metastasis and the Efficacy of Immune Checkpoint Blockade in Non-small Cell Lung Cancer;Current Cancer Drug Targets;2024-01